IXHL Incannex Healthcare Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Sep 25, 2026
$3,21
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,26rendah 52m
$6,46tinggi 52m
Kapitalisasi Pasar (MRQ)
$40M
P/E
-1.9
EPS
$-1.66
Pendapatan
$0
lencana Anda
Rentang 52M
$0–$6
Peringkat Analis
BUY
Target Harga
$18
P/E
-1.9
ROE
-27.4%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
IXHL Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$3.21
Kapitalisasi Pasar (MRQ)
$40M
P/E
-1.9
EPS
$-1.66
Pendapatan
$0
ROE
-27.4%
Rentang 52M
$0–$6
IXHL Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 27 Feb. 2026 | 1-for-30 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$02024-06-30 → 2026-06-30
EPS$-1.662023-06-30 → 2026-06-30
Arus Kas Bebas$-13M2024-06-30 → 2026-06-30
Margin bersih·2024-06-30 → 2025-06-30
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | IXHL | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -1.9rata-rata 5T ≈-1.7 | ≈-1.7 | · | · | |
| P/B (MRQ) | 0.6rata-rata 5T ≈2.7 | ≈2.7 | · | · | |
| Harga / FCF (TTM) | -3.1 | · | · | · | |
| Harga / Arus Kas (TTM) | -3.1rata-rata 5T ≈-3.3 | ≈-3.3 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.6rata-rata 5T ≈2.7 | ≈2.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | IXHL | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -41.3%rata-rata 5T ≈-127.3% | ≈-127.3% | · | · | |
| ROE | -27.4%rata-rata 5T ≈-267.8% | ≈-267.8% | · | · | |
| ROIC | -34.2% | · | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | IXHL | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 48.8rata-rata 5T ≈18.2 | ≈18.2 | · | · | |
| Quick Ratio (Rasio Cepat) | 45.4rata-rata 5T ≈16.2 | ≈16.2 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | IXHL | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 616.7% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | IXHL | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.0 | ≈0.0 | · | · | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$0.00 | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-1082.7%
Laporan Berikutnya
Nov 12, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Sep. 2026 | Nov 12, 2026 | $-11.23 | $-0.50 | -2160.3% |
| 30 Juni 2026 | $-0.20 | $-0.76 | 74.1% | |
| 31 Maret 2026 | Mei 15, 2026 | $-0.49 | $-0.94 | 48.1% |
| 31 Des. 2025 | $-22.83 | $-0.94 | -2316.1% | |
| 30 Sep. 2025 | $-22.95 | $-0.94 | -2328.8% | |
| 30 Juni 2025 | $-15.30 | $-89.29 | 82.9% | |
| 31 Maret 2025 | $-238.98 | $-22.16 | -978.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Revenue | $0 | $86.0K | $12.0K | |
| R&D Expense | $5M | $11M | $13M | |
| SG&A Expense | $18M | $13M | $17M | |
| Operating Expenses | $23M | $24M | $30M | |
| Operating Income | $-23M | $-24M | $-30M | |
| Interest Income | $21.0K | $62.0K | $206.0K | |
| Other Non-op | $4M | $-23M | $12M | |
| Pretax Income | $-19M | $-47M | $-18M | |
| Income Tax | $0 | $0 | $30.0K | |
| Net Income | $-19M | $-47M | $-18M | |
| EPS (Basic) | $-1.66 | $-40.82 | $-1.15 | |
| EPS (Diluted) | $-1.66 | $-40.82 | $-1.15 | |
| Shares (Basic) | 11,658,374 | 1,148,476 | 16,164,338 | |
| Shares (Diluted) | 11,658,374 | 1,148,476 | 16,164,338 | |
| EBITDA | $-23M | $-24M | $-30M |
Neraca
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Cash & Equivalents | $68M | $15M | $6M | |
| Prepaid Expense | $537.0K | $791.0K | $507.0K | |
| Current Assets | $73M | $20M | $16M | |
| PP&E (Net) | $4.0K | $227.0K | $472.0K | |
| PP&E (Gross) | $648.0K | $495.0K | $598.0K | |
| Accum. Depreciation | $643.0K | $268.0K | $126.0K | |
| Total Assets | $73M | $20M | $17M | |
| Accounts Payable | · | · | $5M | |
| Accrued Liabilities | $242.0K | $661.0K | $5M | |
| Current Liabilities | $1M | $7M | $6M | |
| Capital Leases | $34.0K | $74.0K | $210.0K | |
| Total Liabilities | $6M | $7M | $6M | |
| Common Stock | $38.0K | $20.0K | $2.0K | |
| Paid-in Capital | $248M | $174M | $125M | |
| Retained Earnings | $-177M | $-158M | $-111M | |
| AOCI | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $67M | $13M | $11M | |
| Liabilities + Equity | $73M | $20M | $17M | |
| Shares Outstanding | 12,544,298 | 6,479,333 | 588,094 |
Arus Kas
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| D&A | $240.0K | $246.0K | $103.0K | |
| Stock-based Comp | $8M | $3M | $9M | |
| Operating Cash Flow | $-13M | $-13M | $-16M | |
| CapEx | $10.0K | $8.0K | $277.0K | |
| Investing Cash Flow | $-94.0K | $-8.0K | $-277.0K | |
| Stock Issued | $79M | $48M | · | |
| Stock Repurchased | $9M | $0 | · | |
| Net Stock Activity | $69M | $48M | · | |
| Financing Cash Flow | $66M | $21M | · | |
| Free Cash Flow | $-13M | $-13M | $-16M |
Profitabilitas
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Operating Margin | · | -27661.6% | -250341.7% | |
| Net Margin | · | -54517.4% | -153825.0% | |
| Pretax Margin | · | -54517.4% | -153575.0% | |
| EBITDA Margin | · | -27661.6% | -250341.7% | |
| ROA | -41.3% | -250.1% | -90.4% | |
| ROE | -27.4% | -653.3% | -122.7% | |
| ROIC | -34.2% | · | -268.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Current Ratio | 48.8 | 2.9 | 2.9 | |
| Quick Ratio | 45.4 | 2.2 | 1.0 |
Efisiensi
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Book Value / Share | $5.37 | $0.07 | $0.71 | |
| Revenue / Share | $0.00 | $0.00 | $0.00 | |
| Cash Flow / Share | $-1.10 | $-0.36 | $-0.98 | |
| Cash / Share | $5.40 | $0.08 | $0.37 | |
| EPS (TTM) | $-1.66 | $-1.35 | $-1.15 |
Tingkat Pertumbuhan
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Revenue YoY | · | 616.7% | · |
Valuasi (TTM)
| Metrik | Tren | 2026 | 2025 | 2024 |
|---|---|---|---|---|
| Revenue TTM | $0 | $86.0K | $12.0K | |
| Net Income TTM | $-19M | $-47M | $-18M | |
| Market Cap | $47M | $42M | $47M | |
| P/E | -2.3 | -0.2 | -2.6 | |
| P/S | · | 488.2 | 3888.9 | |
| P/B | 0.7 | 3.1 | 4.2 | |
| P / Tangible Book | 0.7 | 3.1 | 4.2 | |
| P / Cash Flow | -3.7 | -3.4 | -2.9 | |
| P / FCF | · | -3.4 | -2.9 | |
| Earnings Yield | -44.1% | -625.0% | -39.1% |
Laporan Laba Rugi
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | · | $12.0K | $74.0K | |
| R&D Expense | $1M | $321.0K | $2M | $1M | $4M | $3M | $1M | $3M | |
| SG&A Expense | $4M | $4M | $5M | $6M | $4M | $2M | $4M | $3M | |
| Operating Expenses | $5M | $4M | $7M | $7M | $8M | $5M | $5M | $6M | |
| Operating Income | $-5M | $-4M | $-7M | $-7M | $-8M | $-5M | $-5M | $-6M | |
| Interest Income | · | · | · | · | $2.0K | $4.0K | $28.0K | $28.0K | |
| Other Non-op | $3M | $165.0K | $474.0K | $387.0K | $-24M | $1M | $-890.0K | $834.0K | |
| Pretax Income | $-2M | $-4M | $-7M | $-6M | $-32M | $-4M | $-6M | $-5M | |
| Net Income | $-2M | $-4M | $-7M | $-6M | $-32M | $-4M | $-6M | $-5M | |
| EPS (Basic) | $-1.27 | $-0.35 | $-0.02 | $-0.02 | $-34.01 | $-6.19 | $-0.33 | $-0.29 | |
| EPS (Diluted) | $-1.27 | $-0.35 | $-0.02 | $-0.02 | $-34.01 | $-6.19 | $-0.33 | $-0.29 | |
| Shares (Basic) | · | 12,348,460 | 349,464,317 | 310,309,659 | · | 654,418 | 17,624,422 | 17,642,832 | |
| Shares (Diluted) | · | 12,348,460 | 349,464,317 | 310,309,659 | · | 654,418 | 17,624,422 | 17,642,832 | |
| EBITDA | · | $-4M | $-7M | $-7M | · | $-5M | $-5M | $-6M |
Neraca
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $68M | $74M | $69M | $73M | $15M | $7M | $2M | $4M | |
| Prepaid Expense | $537.0K | $405.0K | $431.0K | $486.0K | $791.0K | $416.0K | $417.0K | $489.0K | |
| Current Assets | $73M | $80M | $75M | $78M | $20M | $16M | $11M | $15M | |
| PP&E (Net) | $4.0K | $47.0K | $108.0K | $168.0K | $227.0K | $277.0K | $273.0K | $428.0K | |
| PP&E (Gross) | $648.0K | $572.0K | $506.0K | $503.0K | $495.0K | $597.0K | $560.0K | $625.0K | |
| Accum. Depreciation | $643.0K | $525.0K | $398.0K | $335.0K | $268.0K | $320.0K | $287.0K | $197.0K | |
| Total Assets | $73M | $80M | $75M | $79M | $20M | $16M | $11M | $16M | |
| Accrued Liabilities | $242.0K | $202.0K | $133.0K | $154.0K | $661.0K | $4M | $3M | $7M | |
| Short-term Debt | · | · | · | · | · | $1M | $1M | · | |
| Current Liabilities | $1M | $2M | $2M | $2M | $7M | $7M | $6M | $9M | |
| Capital Leases | $34.0K | $42.0K | $53.0K | $64.0K | $74.0K | $104.0K | $152.0K | $221.0K | |
| Total Liabilities | $6M | $5M | $2M | $2M | $7M | $9M | $10M | $9M | |
| Long-term Debt | · | · | · | · | · | · | $2M | · | |
| Total Debt | · | · | · | · | · | $1M | $4M | · | |
| Common Stock | $38.0K | $41.0K | $36.0K | $35.0K | $20.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $248M | $253M | $247M | $244M | $174M | $137M | $126M | $126M | |
| Retained Earnings | $-177M | $-174M | $-170M | $-164M | $-158M | $-126M | $-122M | $-116M | |
| AOCI | $-4M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | |
| Stockholders' Equity | $67M | $75M | $73M | $77M | $13M | $7M | $965.0K | $7M | |
| Liabilities + Equity | $73M | $80M | $75M | $79M | $20M | $16M | $11M | $16M | |
| Shares Outstanding | 12,544,298 | 13,683,121 | 359,218,871 | 347,705,507 | 6,479,333 | 17,785,235 | 17,785,235 | 17,642,832 |
Arus Kas
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $50.0K | $65.0K | $59.0K | $66.0K | $61.0K | $-5.0K | $126.0K | $64.0K | |
| Stock-based Comp | $1M | $1M | $2M | $3M | $1M | $417.0K | $435.0K | $459.0K | |
| Operating Cash Flow | $3M | $-2M | $-5M | $-9M | $-1M | $-3M | $-6M | $-2M | |
| CapEx | $-1.0K | $5.0K | $4.0K | $2.0K | $0 | $0 | · | · | |
| Investing Cash Flow | $-30.0K | $-18.0K | $-4.0K | $-42.0K | $0 | $0 | · | · | |
| Stock Issued | $50.0K | $7M | $2M | $69M | $36M | · | · | · | |
| Stock Repurchased | $7M | $1M | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | $69M | · | · | · | · | |
| Financing Cash Flow | $-7M | $5M | $927.0K | $67M | $10M | $8M | $4M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $-2M | |
| Free Cash Flow | · | · | · | $-9M | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | -41700.0% | -8451.3% | |
| Net Margin | · | · | · | · | · | · | -49116.7% | -7324.3% | |
| Pretax Margin | · | · | · | · | · | · | -49116.7% | -7324.3% | |
| EBITDA Margin | · | · | · | · | · | · | -41700.0% | -8451.3% | |
| ROA | · | -8.1% | -15.2% | -13.5% | · | -23.7% | -35.2% | -67.5% | |
| ROE | · | -9.4% | -17.5% | -15.3% | · | -36.8% | -59.4% | -164.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 41.6 | 48.3 | 47.5 | · | 2.1 | 1.8 | 1.6 | |
| Quick Ratio | · | 38.6 | 44.5 | 44.5 | · | 0.9 | 0.4 | 0.4 | |
| Debt / Equity | · | · | · | · | · | 0.2 | 3.9 | · | |
| LT Debt / Equity | · | · | · | · | · | · | 2.5 | · |
Efisiensi
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $5.50 | $0.20 | $0.22 | · | $0.42 | $0.05 | $0.37 | |
| Revenue / Share | · | · | · | · | · | · | $0.00 | $0.00 | |
| Cash Flow / Share | · | · | · | $-0.03 | · | · | · | $-0.12 | |
| Cash / Share | · | $5.44 | $0.19 | $0.21 | · | $0.38 | $0.12 | $0.21 | |
| EPS (TTM) | · | $-34.40 | $-40.24 | $-40.55 | · | $-7.17 | $-1.36 | $-1.36 |
Valuasi (TTM)
| Metrik | Tren | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | · | $-48M | $-48M | $-48M | · | $-22M | $-24M | $-23M | |
| Market Cap | · | $41M | $129M | $161M | · | $12M | $38M | $35M | |
| Enterprise Value | · | · | · | · | · | $7M | $39M | · | |
| P/E | · | -0.1 | -0.0 | -0.0 | · | -0.1 | -1.6 | -1.5 | |
| P/B | · | 0.5 | 1.8 | 2.1 | · | 1.6 | 39.1 | 5.3 | |
| P / Tangible Book | · | 0.5 | 1.8 | 2.1 | · | 1.6 | 39.1 | 5.3 | |
| P / Cash Flow | · | · | · | -17.6 | · | · | · | -16.0 | |
| Earnings Yield | · | -1146.7% | -11240.2% | -8739.2% | · | -1059.1% | -64.1% | -68.3% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Pendapatan | $0 | $86.0K | $12.0K | · |
| Margin Operasi % | · | -27661.6% | -250341.7% | · |
| Laba Bersih | $-19M | $-47M | $-18M | $-49M |
| EPS Dilusian | $-1.66 | $-40.82 | $-1.15 | $-3.32 |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Rasio Lancar | 48.8 | 2.9 | 2.9 | · |
| Rasio Cepat | 45.4 | 2.2 | 1.0 | · |
| Metrik | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
| Arus Kas Bebas | $-13M | $-13M | $-16M | · |
Pemilik institusional (13F) 1 pengaju · $22 total · Per tanggal 30 Juni 2025
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
1
Nilai yang dipegang
$22
Posisi baru
0
Posisi yang keluar
26
Aktivitas institusional — Q1 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 0 | 26 | 0 | 1 | · |
Dibandingkan dengan Q4 2025. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya. Perubahan vs kuartal sebelumnya tidak ditampilkan: cakupan pengaju terlalu berbeda antara kedua kuartal ini untuk perbandingan yang andal.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Iron Horse Wealth Management, LLC | $22 | 100 | 100,00% | Saham |
Orang dalam perusahaan 7 orang dalam · 3 pejabat · 5 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Joel Latham | CEO and President | 14 Nov. 2025 A | 24.186.177 | 0 | 0 | $0 |
| Joseph Swan | CFO, Treasurer and Secretary | 14 Nov. 2025 A | 921.358 | 0 | 0 | $0 |
| Luigi M. Barbato | Chief Medical Officer | 23 Okt. 2024 A | 100.476 | 0 | 0 | $0 |
| Troy Valentine | Direktur | 14 Nov. 2025 A | 12.001.858 | 0 | 0 | $0 |
| Robert Clark | Direktur | 14 Nov. 2025 A | 1.786.956 | 0 | 0 | $0 |
| Peter Widdows | Direktur | 14 Nov. 2025 A | 1.957.803 | 0 | 0 | $0 |
| George Anastassov | Direktur | 14 Nov. 2025 A | 2.456.677 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
IXHL Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 7 analis
BELI
Target median
$17.72
+451,9%
2 28,6%
Beli Kuat
4 57,1%
Beli
1 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
1 analis · 2026-09-30Target rata-rata $17.72 +451,9%
Rendah$17.72
Rata-rata$17.72
Tinggi$17.72
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-K diajukan Sep 25, 2026